B. Riley Financial Varied

B. Riley Securities Served as Financial Advisor and Lead Placement Agent for Radiopharm Theranostics in a $46.9 Million Financing

LOS ANGELES, July 3, 2024 -- B. Riley Securities, Inc. ("B. Riley"), a leading middle market investment bank, is pleased to have led a $46.9 million financing for Radiopharm Theranostics Limited (RAD or "The Company"), an ASX listed clinical stage biotechnology company developing targeted radiopharmaceutical therapies and diagnostics for multiple types of cancer. The financing consisted of a $4.99 million strategic investment and a $41.9 million institutional placement.

B. Riley acted as financial advisor to RAD and facilitated the strategic investment and asset rights and development agreement with Lantheus (LNTH), an ASX listed clinical stage biopharmaceutical company that develops and commercializes products for imaging, cardiology, and endocrinology, and then led the placement financing. For more information about the deal, click here.

Patrice McNicoll, Co-Head of Investment Banking at B. Riley Securities, commented, "We are excited to partner with RAD, helping them continue their important work developing the next generation of targeted radiotherapies and diagnostics to fight cancer. We were able to leverage our expertise within radiopharma, in addition to strategic and investor relationships to effectuate a transformative transaction. The capital we helped RAD raise fully funds the pipeline through multiple clinical data readouts."

B. Riley's investment banking team was led by Patrice McNicoll, Matt Feinberg, Brian Taylor, Melissa Woodson and Daniel Lewis, and included Connor Boyle and Noah Rich. Our capital markets team was led by Chad Ritchie and included Dawn Farrell, Kathy Innis and Sam Cook.


About B. Riley Securities
B. Riley has served as a preeminent fixture in middle market brokerage and investment banking for over 25 years. We provide a full suite of investment banking and capital markets services to companies, financial sponsors, and institutional investors across all industry verticals. Investment banking services include initial, secondary and follow-on offerings, institutional private placements, merger and acquisition (M&A) advisory, SPACs, debt financings, corporate restructuring and recapitalization. Widely recognized for our thematic proprietary equity research, clients benefit from B. Riley's extensive network, industry expertise, and proven execution capabilities of our end-to-end financial services platform. Please see disclosures about B. Riley Securities Research here. The firm is a subsidiary of B. Riley Financial (Nasdaq: RILY). For more information, visit www.brileysecurities.com.

In addition to B. Riley Securities, B. Riley Financial operates through several wholly owned subsidiaries, including: B. Riley Capital Management, an SEC-registered investment adviser, which provides advisory services to private funds; B. Riley Wealth Management, a FINRA-registered broker-dealer and member SIPC, which offers securities and variable insurance products; B. Riley Wealth Advisors, an SEC-registered investment adviser, which provides fee-based asset management and advisory services; B. Riley Wealth Portfolio Advisers, an SEC-registered investment adviser, which provides advisory and sub-advisory services, some through separately managed accounts using model portfolio; B. Riley Wealth Private Shares, an SEC-registered investment adviser, which provides advisory services to private funds; and B. Riley Principal Investments which makes proprietary investments in other businesses.

Copyright © 2024
B. Riley Financial all rights reserved.